April 19, 2011
European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVONEX® PEN™ for patients with relapsing multiple sclerosis (MS)
- /
- /
News Medical Biogen Idec announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has…
